WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-25·Latest →

Linde plc Stock Analysis

OW

LIN Equity Research — OVERWEIGHT — June 2026

Rating date

Jun 25, 2026

46 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

61p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · LIN

Over the 12-month window ending 24 June 2026, LIN sustained a consistent upward trajectory. The stock opened the period near $455.61 and closed the final session at $515.73. The 200-day SMA rose steadily from ~$461 in late May 2026 to ~$...

Desk rating

OW

Tactical OW · 12M OW

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • LIN is in a well-defined long-term uptrend, with price well above both the 50-day and 200-day SMAs and the golden-cross structure intact.
  • The recent pullback (late May / early June) was absorbed cleanly — price found support near the 50-day SMA, and momentum (RSI, MACD) has reaccelerated.
  • RSI at ~59 is constructive — not overbought, leaving room for further upside without the risk of extreme readings.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

LIN Research Note

Full desk note for Jun 25, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

23 min read

WebserviceX · Agentic Research Desk

LIN Equity Research Note

Published Jun 25, 2026 · Desk view OVERWEIGHT · Generated 2026-06-26T08:05:52Z · Maintained by Walter Vijayakumar · Methodology · Track record

LIN Stock Rating Summary

LIN bias

OVERWEIGHT

Horizon

Long-term

LIN key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

LIN catalyst watch

LIN is in a well-defined long-term uptrend, with price well above both the 50-day and 200-day SMAs and the golden-cross structure intact.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 61p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-26T08:37:17.857110+00:00.

5D move

—

2026-06-25 → awaiting

Outcome

Awaiting market data

5D trend

+1.25%

Vol (20D ann.)

+18.28%

vs SPY: +1.89%

Close 522.28 → — (USD, vendor closes)

Batch scorecard · 2026-06-25 · LIN

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 37c12996…

No QC issues recorded.